09/26/2014 - 4:40pm

Drug Store News director of continuing education and clinical content Suzanne Feeney, PharmD, will take over the Drug Store News twitter handle @drugstorenews, as part of the global #Pharmacist tweet-a-thon on Thursday, Oct. 2.

09/26/2014 - 11:42am

As part of its new Women’s Wellness initiative, Schnucks Pharmacies has announced that four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) will be available for $9 with a valid prescription.

09/24/2014 - 4:41pm

In celebration of the 30th anniversary of the enactment of the Drug Price Competition and Patent Term Restoration Act, also known as the “Hatch-Waxman” Act, the National Association of Chain Drug Stores issued a statement to reflect on the evolution of providing patient access to generic medications and noted that it is looking forward to further progress in the years ahead.

09/24/2014 - 11:24am

Pharmacists around the globe are being called upon by the International Pharmaceutical Federation to take part in World Pharmacists Day 2015 through social media on Thursday.

09/23/2014 - 10:16am

Care4Today Mobile Health Manager, a platform designed to support and motivate people to stay on schedule with their medications, has announced the launch of a patient dashboard for health care providers and pharmacies to provide timely monitoring of self-reported medication adherence for their patients.

09/17/2014 - 10:09am

Misfit, makers of Shine, on Wednesday announced its second wearable product, Misfit Flash, a versatile and easy-to-use fitness and sleep monitor.

09/16/2014 - 1:59pm

Lupin has entered into a long-term partnership with Merck Serono for the implementation of the company's general medicines portfolio expansion initiative in emerging markets, helping to fulfill local needs for affordable medications.

09/16/2014 - 8:29am

More than 75 locally-owned community pharmacies throughout Arkansas are enhancing patient care by participating in a unique nine-month medication adherence program.

09/15/2014 - 11:53am

Mylan announced that its subsidiary, Mylan Labs Limited, has signed an agreement with Gilead Science under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single-tablet regimen of ledipasvir/sofosbuvir in 91 developing countries.